LUNESTA to Sleep well

Characteristics and treatment to relieve symptoms of insomnia and narcolepsy

“I have lived the last 4 years of my life with insomnia problems. My life really turned into a nightmare. I work as a manager in a company and I feel that I have no energy, I am tired and drowsy during the day. I find it very difficult to find a solution and as time goes by the situation gets worse, because I start to despair because I see that it impacts my work. ”

Millions of people in the world suffer some sleep disorder, suffering serious consequences like the ones just described. We can define insomnia as the impossibility of sleeping the necessary time to be rested and active the next day. It is well known that the number of hours of sleep varies from person to person. There are people who can sleep very few hours and yet this does not affect their well-being and can perform the tasks of their daily life the next day without problems. But the problem appears when the quality and quantity of time that we sleep impacts in some or several of the spheres of our life.

According to some statistical data, about 40% of the population worldwide suffers from insomnia. At the same time, it is estimated that women and older people suffer the most from this type of pathology. It is also important to note that there is an important sector of society that has chronic insomnia and it is believed that half of these people manifest a psychiatric pathology.

Despite being a disorder that can lead people to certain degrees of disability, it is not usually a reason for consultation since it is a pathology that is sometimes naturalized and is about living daily with it. A study in the United States showed that more than half of the people who are treated at the primary care level say that they have insomnia if the doctor asks about their sleep habits. Another 30% talk to their usual doctor and only 5% seek the specialist specifically to obtain effective treatment for the purpose of resolving this condition. Other statistics say that people who experience insomnia that is maintained for more than a month are between the range of 20% to 27% of the population.

There are several drugs that help relieve symptoms associated with sleep problems such as insomnia. In another article we have referred to zolpidem as one of the drugs that provides excellent efficacy to solve the problems that insomnia brings. However it is important to approach the reader with other pharmacological options that have also shown very good results to end insomnia problems.

One of these medicines that many people take and have managed to solve their problem of insomnia is the zoplicone. This drug possesses hypnotic and sedative properties and in turn has proven to be extremely useful in counteracting anxiety disorders. Most of the studies performed so far agree that the standard dose for the treatment of insomnia is 8 mg daily. It must be taken into account that zoplicone has a latency, total sleep time, depth and quality of sleep. Improved sleep maintenance and the Digit Symbol Substitution Test (DSST) score were also detected, suggesting the absence of residual effects. There was also no rebound tolerance or insomnia when the drug was suspended. The safety and efficacy of Lunesta 3 mg long-term treatment, observed in a 6-month study, indicate its usefulness as an extended therapy. Treatment improved sleep characteristics without intolerance or decreased efficacy.

According to several studies, the balance that must exist between the sleep-wake pair is crucial for a proper functioning of the central nervous system. This allows to understand the influence at the clinical level that reach the different sleep disorders. It is estimated that about 25% of the population suffers some sleep disease and about 80% have suffered at some point in their life, some episode related to sleep disturbances. In a study led by Martinez and colleagues, the purpose was to analyze the effectiveness of Lunesta as well as its possible adverse effects. The aspects evaluated in the investigation consisted of: sleep hours; amount of nocturnal awakenings; general condition the next day; points of view of both doctors and patients; the relationship between age and number of quality sleep hours and lastly the identification of side effects.

The observations made by the investigators first determined that Lunesta was able to increase the hours of sleep compared to the time before treatment in 65% of the studied subjects of both sexes. Meanwhile, nocturnal awakenings significantly decreased: before taking Lunesta, 84% of the patients showed more than 4 awakenings. After treatment, that number decreased to only 16%. Regarding the opinions of physicians, 94% of the patients studied showed an improvement in their disorder. When the patients themselves were consulted, 92% of them considered that their sleep habits had improved.

Based on these data, researchers found that Lunesta is an effective drug to counteract the various symptoms that manifest in sleep disorders. They also affirmed that this medicine adequately maintains the age / sleep relationship, keeping the same profile before and after treatment.

To conclude, it was synthesized that Lunesta should be considered as a suitable alternative thanks to that it increases the hours of sleep and the number of awakenings decreases. It also does not interfere with the relationship between age and sleep. Finally, no major adverse events have been reported.

These data should not be minimized if one considers that insomnia is a pathology that can seriously affect the daily life of those who suffer from it. It is a picture that presents significant difficulties to solve it and often becomes a chronic disease.

Finally, it is also useful to bring the reader some considerations to pay attention to before buying Lunesta. No studies have been conducted to prove the efficacy of this drug during pregnancy. Therefore, it is suggested that women in these conditions refrain from taking Lunesta. Likewise, it is not advisable to use it in women who are breastfeeding, since Lunesta concentrates on breast milk.

Drinking alcohol while you are being treated with Lunesta should be discontinued because it may increase the sedative effect of the medication. The same can happen if Lunesta is taken simultaneously with some depressant medication of the central nervous system.

  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

LOOKING TO BUY TRAMADOL ONLINE ?